USPTO Examiner HAYNES DAWN TRINAH - Art Unit 3686

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18602895EARLY DETECTION OF CONDITIONS AND/OR EVENTSMarch 2024March 2026Abandon2410NoNo
18686979SELF-SERVICE STATION AND MEDICAL INFORMATION MANAGEMENT SYSTEM FOR SCREENING MEDICAL CONSULTATIONSFebruary 2024February 2026Abandon2410NoNo
18374004Method for Evaluating Biomarkers in a Biological SampleSeptember 2023November 2025Abandon2610NoNo
18473405MEDICATION TARGET PERSON MANAGEMENT SYSTEM, MANAGEMENT METHOD, MANAGEMENT CONTROL APPARATUS AND PROGRAM STORAGE MEDIUMSeptember 2023January 2026Abandon2710NoNo
18463685MACHINE LEARNING METHOD FOR ENHANCING CARE OF A PATIENT USING VIDEO AND AUDIO ANALYTICSSeptember 2023December 2025Abandon2710NoNo
18269013INFORMATION PROCESSING METHOD, INFORMATION PROCESSING APPARATUS, AND NONTRANSITORY COMPUTER-READABLE STORAGE MEDIUMJune 2023December 2025Abandon3010NoNo
18338828SYSTEMS AND METHODS FOR REGISTERING AND REPORTING IN A TESTING PROGRAMJune 2023August 2025Abandon2610NoNo
18316678Collaborative Medical Diagnosis and Treatment System and Method of UseMay 2023September 2025Abandon2810NoNo
18168802Information Processing Apparatus, Information Processing Method, and ProgramFebruary 2023January 2026Abandon3520NoNo
18003900SYSTEM, METHOD AND COMPUTER PROGRAM FOR PROVIDING AN ASSESSMENT OF A MEDICAL RISK, METHOD FOR OBTAINING A MODEL FOR THE SYSTEM, METHOD FOR ASSESSING A MEDICAL RISK AND NUTRITIONAL SUPPLEMENTSDecember 2022June 2025Abandon3001NoNo
18069991INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING SYSTEM, INFORMATION PROCESSING METHOD, AND PROGRAMDecember 2022December 2025Abandon3620YesNo
18076448SYSTEM FOR PROVIDING DIGITAL THERAPEUTIC AGENT TO TREAT TEMPOROMANDIBULAR JOINT DISEASE OF PATIENTDecember 2022October 2025Abandon3420YesNo
17964869MODIFIABLE PHARMACEUTICAL PROTOCOL FOR MIGRAINE TREATMENT AND ASSESSMENT OF DRUG EFFICACY THEREOFOctober 2022April 2025Abandon3010NoNo
17956012SYSTEM AND METHOD FOR INTELLIGENT DIAGNOSISSeptember 2022June 2025Abandon3211NoNo
17951484BIOLOGICAL FUNCTION ESTIMATION DEVICE AND BIOLOGICAL FUNCTION ESTIMATION METHODSeptember 2022January 2026Allow4030YesNo
17891625SYSTEMS AND METHODS FOR VISUALIZATION OF MEDICAL RECORDSAugust 2022June 2025Abandon3420YesNo
17856058SYSTEM AND METHOD FOR REAL-TIME PREDICTION OF HOSPITAL DISCHARGE DISPOSITION AND DEFERRING CLINICAL SERVICESJuly 2022September 2025Abandon3820NoNo
17757685HEARING ASSISTANCE DEVICE MODEL PREDICTIONJune 2022May 2025Abandon3520NoNo
17779857Monitoring System, Monitoring Method, and Monitoring ProgramMay 2022May 2025Abandon3620NoNo
17752820DISEASE RISK PREDICTION METHOD AND SYSTEM BASED ON BIOLOGICAL AGE USING MEDICAL CHECK-UP CLINICAL DATA INDEPENDENT OF DYSLIPIDEMIA DATAMay 2022November 2024Abandon3010NoNo
17749819METHOD AND SYSTEM FOR ELECTRONIC MEDICAL RECORD CREATION AND MEDICAL BILLINGMay 2022October 2024Abandon2910NoNo
17768970PATIENT CONDITION PREDICTION APPARATUS, PATIENT CONDITION PREDICTION METHOD, AND COMPUTER PROGRAMApril 2022December 2024Abandon3210YesNo
17654806SYSTEMS AND METHODS FOR POOLED SAMPLE COLLECTION AND IMPLEMENTING TESTING PROGRAMSMarch 2022December 2024Abandon3310NoNo
17691341SYSTEMS AND METHODS FOR VERIFYING PRESCRIPTIONSMarch 2022January 2025Abandon3420YesNo
17641480CLINICAL DECISION SUPPORT SCHEDULING AND ALERTSMarch 2022October 2024Abandon3110NoNo
17645618SYSTEM TO PROVIDE TIMELY PRESCRIPTION INFORMATIONDecember 2021March 2025Abandon3920YesNo
17558288CLINICAL DATA CONNECTOR AND CLINICAL DOCUMENT COLLECTOR FOR INDIVIDUAL ACCESSDecember 2021October 2024Abandon3420NoNo
17558336AI Platform System and MethodDecember 2021April 2025Abandon4020YesNo
17558277AI Platform System and MethodDecember 2021March 2025Abandon3920YesNo
17558319AI Platform System and MethodDecember 2021September 2025Abandon4520YesNo
17555704CONTAINER VAULT SYSTEMDecember 2021July 2024Abandon3120YesNo
17618683METHOD AND SYSTEM FOR MANAGING MEDICAL PROCESSESDecember 2021July 2024Abandon3110NoNo
17614485METHOD AND SYSTEM FOR PERSONALIZING AND STANDARDIZING CANNABIS, PSYCHEDELIC AND BIOACTIVE PRODUCTSNovember 2021June 2024Abandon3110NoNo
17603818AUXILIARY METHOD FOR DIAGNOSIS OF LOWER URINARY TRACT SYMPTOMSNovember 2021November 2024Abandon3720YesNo
17499220SYSTEM AND METHOD FOR PERSONALIZATION OF SLEEP RESTRICTION THERAPYOctober 2021January 2026Abandon5140NoYes
17481395SYSTEM AND METHOD FOR PROVIDING DISEASE EARLY WARNINGSeptember 2021September 2024Abandon3620YesNo
17476883METHODS AND APPARATUS FOR A TELECARE COMMUNICATION SYSTEMSeptember 2021March 2026Abandon5450YesNo
17460024METHOD, APPARATUS FOR PREDICTING EPIDEMIC SITUATION, DEVICE, STORAGE MEDIUM AND PROGRAM PRODUCTAugust 2021September 2024Abandon3610NoNo
17458103INTEGRATING MANAGEMENT OF MOVEMENT SESSIONS WITH ELECTRONIC RECORD SYSTEM REPORTING REQUIREMENTSAugust 2021July 2025Abandon4740YesNo
17368850METHOD FOR CALCULATING HIGH RISK ROUTE OF ADMINISTRATIONJuly 2021May 2024Abandon3520YesNo
17361717MACHINE LEARNING-BASED ADJUSTMENT OF EPIDEMIOLOGICAL MODEL PROJECTIONS WITH FLEXIBLE PREDICTION HORIZONJune 2021August 2024Abandon3820YesNo
17358561PRESERVING DATA INTEGRITY IN TASKS ACROSS A COMPUTING SYSTEMJune 2021October 2025Abandon5240YesNo
17340419METHODS AND SYSTEMS FOR LEVERAGING HEALTHCARE CLAIMS FOR A HEALTHCARE PROVIDER SEARCHJune 2021September 2024Abandon4020NoNo
17335371METHOD, APPARATUS, AND NON-TRANSITORY COMPUTER READABLE MEDIUM FOR MANAGING MEDICAL IMAGESJune 2021May 2024Abandon3520NoNo
17335157ELECTRONIC DEVICE, COMPUTER-READABLE NON-TRANSITORY RECORDING MEDIUM STORING PHARMACY RESERVATION PROGRAM, AND PHARMACY RESERVATION SYSTEMJune 2021January 2024Abandon3110NoNo
17243649MITIGATING OPEN SPACE HEALTH RISK FACTORSApril 2021February 2026Abandon5760YesNo
17239893CONSUMPTION WEARABLEApril 2021March 2024Abandon3410NoNo
17239777SIDE EFFECT AND SYMPTOM RELIEFApril 2021January 2024Abandon3310NoNo
17231937System and Method for Obtaining Post-Infection ClearanceApril 2021July 2024Abandon3920NoNo
17285230NURSING ASSISTANCE DEVICE, NURSING ASSISTANCE METHOD, AND RECORDING MEDIUMApril 2021April 2024Abandon3610YesNo
17226001System and Method for Obtaining ClearanceApril 2021June 2024Abandon3820NoNo
17217925System and Method for Audible Prescription Label Information Using RFID Prescription PackagingMarch 2021July 2025Allow5250YesYes
17213708SYSTEM AND METHODS FOR A CLOUD-BASED USER-INTERACTIVE PARTOGRAMMarch 2021November 2025Abandon5650YesNo
17278539SYSTEM AND METHOD TO IMPROVE INTERACTION BETWEEN USERS THROUGH MONITORING OF EMOTIONAL STATE OF THE USERS AND REINFORCEMENT OF GOAL STATESMarch 2021March 2024Abandon3610NoNo
17205457COMPUTING DEVICE, METHOD AND COMPUTER PROGRAM PRODUCT FOR CONSTRUCTING A CONSOLIDATED MESSAGEMarch 2021July 2025Allow5240NoNo
17180301INFLUENCING END-STAGE RENAL DISEASE OUTCOMES THROUGH PREDICTING PHYSIOLOGICAL PARAMETERS AND DETERMINING DOSING RECOMMENDATIONSFebruary 2021November 2023Abandon3310NoNo
17173124METHOD, APPARATUS AND DEVICE FOR PROCESSING DISEASE INFORMATION, AND STORAGE MEDIUMFebruary 2021November 2023Abandon3410NoNo
17159030METHODS AND SYSTEMS FOR HEALTH MANAGEMENTJanuary 2021November 2023Abandon3410NoNo
17157554ELECTRONIC MEDICAL RECORD SYSTEM PROVIDING CROSS-PATIENT DATA POPULATION AND DISPLAYJanuary 2021October 2023Abandon3310NoNo
17145807INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING METHOD, AND NON-TRANSITORY RECORDING MEDIUM ON WHICH PROGRAM FOR INFORMATION PROCESSING IS RECORDEDJanuary 2021December 2024Abandon4830YesNo
17125707SYSTEM FOR INTEGRATING DATA FOR CLINICAL DECISIONS INCLUDING MEDICINE DATA AND GENE DATADecember 2020April 2024Abandon4030NoNo
17247427METHODS AND SYSTEMS FOR IMPROVING HEALTHCARE WORKFLOWDecember 2020May 2025Abandon5340YesNo
17110892PATIENT BED EXIT PREDICTIONDecember 2020December 2023Abandon3720YesNo
17247114MEDICAL RECORD MANAGEMENT BASED ON HUB-AND-SPOKE SYSTEMNovember 2020December 2024Abandon4840YesNo
17100154DEVICE BASED RESPONDER NETWORK ACTIVATION AND VIRTUAL ASSISTANT INTEGRATIONNovember 2020July 2024Abandon4440YesNo
17061086SINGLE CLICK APP CONTROLLED POINT-OF-CARE PHARMACY DRUG DISPENSINGOctober 2020August 2023Abandon3510NoNo
15872274SYSTEM AND METHOD FOR AUTOMATED DIAGNOSIS AND TREATMENTJanuary 2018May 2025Abandon6040YesYes

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner HAYNES, DAWN TRINAH.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
1
Examiner Affirmed
1
(100.0%)
Examiner Reversed
0
(0.0%)
Reversal Percentile
18.0%
Lower than average

What This Means

With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
3
Allowed After Appeal Filing
1
(33.3%)
Not Allowed After Appeal Filing
2
(66.7%)
Filing Benefit Percentile
54.7%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 33.3% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner HAYNES, DAWN TRINAH - Prosecution Strategy Guide

Executive Summary

Examiner HAYNES, DAWN TRINAH works in Art Unit 3686 and has examined 42 patent applications in our dataset. With an allowance rate of 4.8%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 38 months.

Allowance Patterns

Examiner HAYNES, DAWN TRINAH's allowance rate of 4.8% places them in the 1% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by HAYNES, DAWN TRINAH receive 2.43 office actions before reaching final disposition. This places the examiner in the 70% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by HAYNES, DAWN TRINAH is 38 months. This places the examiner in the 31% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a -0.5% benefit to allowance rate for applications examined by HAYNES, DAWN TRINAH. This interview benefit is in the 11% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 5.4% of applications are subsequently allowed. This success rate is in the 2% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 0.0% of cases where such amendments are filed. This entry rate is in the 3% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 20% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 50.0% of appeals filed. This is in the 20% percentile among all examiners. Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.

Petition Practice

When applicants file petitions regarding this examiner's actions, 85.7% are granted (fully or in part). This grant rate is in the 87% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 40% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 43% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.